Literature DB >> 9451926

Antibiotic-resistant gram-positive cocci: implications for surgical practice.

P S Barie1.   

Abstract

Gram-positive infections are causing more serious infections than ever before in surgical patients, who are increasingly aged, ill, and debilitated. Invasive procedures disrupt natural barriers to bacterial invasion, and indwelling catheters may act as conduits for infection. The use of broad-spectrum antibiotics selects for the emergence of resistant pathogens. Potential sites of nosocomial gram-positive infections include the urinary tract, surgical site (including prosthetic devices), intravascular loci, lung and pleural space, facial sinuses, and peritoneal cavity. Responsible organisms include species from the genera Enterococcus and Staphylococcus. Methicillin-resistant strains of Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE) emerged during the 1970s, leading to a marked increase in the use of vancomycin as the treatment of choice. Vancomycin use, in turn, has been implicated (along with widespread cephalosporin use) in the emergence of vancomycin-resistant enterococci (VRE) during the 1990s. Of great concern is the likely emergence of vancomycin-resistant staphylococci, which would constitute a public health emergency. Vancomycin remains the treatment of choice for infections caused by MRSA/MRSE, but rampant inappropriate use (e.g., prophylaxis in non-penicillin-allergic patients, treatment of methicillin-sensitive strains) must be curtailed. Chloramphenicol is increasingly the treatment of choice for serious VRE infections. Infection control policy must also minimize the possibility of transmission. All infected or colonized patients should be isolated and all environmental surfaces considered contaminated. Disposable gloves are mandatory for all patient contact, even incidental contact, and must be disposed of after each patient encounter. Hand-washing (the single most effective infection control measure) is mandatory after glove disposal. Gowns should be worn for direct contact with infected patients and masks used when aerosolization or splashing of secretions is likely.

Entities:  

Mesh:

Year:  1998        PMID: 9451926     DOI: 10.1007/s002689900359

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2.

Authors:  Paulus H S Kwakman; Anje A te Velde; Christina M J E Vandenbroucke-Grauls; Sander J H van Deventer; Sebastian A J Zaat
Journal:  Antimicrob Agents Chemother       Date:  2006-09-25       Impact factor: 5.191

2.  Biosensor for detection of antibiotic resistant Staphylococcus bacteria.

Authors:  Rajesh Guntupalli; Iryna Sorokulova; Eric Olsen; Ludmila Globa; Oleg Pustovyy; Vitaly Vodyanoy
Journal:  J Vis Exp       Date:  2013-05-08       Impact factor: 1.355

3.  RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.

Authors:  Andrea Giacometti; Oscar Cirioni; Yael Gov; Roberto Ghiselli; Maria Simona Del Prete; Federico Mocchegiani; Vittorio Saba; Fiorenza Orlando; Giorgio Scalise; Naomi Balaban; Giorgio Dell'Acqua
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.

Authors:  Naomi Balaban; Yael Gov; Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Fiorenza Orlando; Giuseppina D'Amato; Vittorio Saba; Giorgio Scalise; Sabina Bernes; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

5.  Comparative study on nutrient depletion-induced lipidome adaptations in Staphylococcus haemolyticus and Staphylococcus epidermidis.

Authors:  Yu Luo; Muhammad Afzal Javed; Harry Deneer
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

6.  The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.

Authors:  Oriana Simonetti; Oscar Cirioni; Federico Mocchegiani; Ivana Cacciatore; Carmela Silvestri; Leonardo Baldassarre; Fiorenza Orlando; Pamela Castelli; Mauro Provinciali; Marco Vivarelli; Erika Fornasari; Andrea Giacometti; Annamaria Offidani
Journal:  Int J Mol Sci       Date:  2013-08-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.